Deferasirox Tablet, For Suspension
Product Images NDC 46708-325

5 FDA label images from Alembic Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 46708-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Deferasirox 125mg)

30 Tablets (Deferasirox 125mg)
Deferasirox Tablets for Oral Suspension 125 mg per tablet label from Alembic Pharmaceuticals Limited. The label includes dosage storage instructions, manufacturer address in Gujarat, India, and indicates the package contains 30 tablets. It also states to not chew or swallow whole tablets and requires dispersion in water, orange, or apple juice prior to ingestion.*
FDA Label Image

30 Tablets (Deferasirox 250mg)

30 Tablets (Deferasirox 250mg)
Deferasirox Tablets for Oral Suspension 250 mg per tablet label from Alembic Pharmaceuticals Limited. The label includes dosage form as tablet for oral suspension, storage instructions at controlled room temperature, manufacturer details, NDC 46708-325-30, and indicates a package size of 30 tablets. It also includes directions to disperse tablets in water, orange, or apple juice before ingestion.*
FDA Label Image

30 Tablets (Deferasirox 500mg)

30 Tablets (Deferasirox 500mg)
Deferasirox 500 mg tablets for oral suspension label with NDC 46708-326-30. The label states tablets must be dispersed in water or juice prior to ingestion and contains storage instructions. It includes manufacturer Alembic Pharmaceuticals Limited and a package count of 30 tablets.*
FDA Label Image

Figure 1 (Deferasirox Figure1)

Figure 1 (Deferasirox Figure1)
A bar chart depicting changes in liver iron content (LIC, mg Fe/g dry weight) and serum ferritin (mcg/L) at different dosages (5, 10, 20, 30) with sample sizes ranging from 15 to 115. Liver iron content is represented by white bars, while serum ferritin is represented by black bars. Values show positive changes at lower dosages and negative changes at higher dosages for both parameters.*
FDA Label Image

Structure (Deferasirox Structure)

Structure (Deferasirox Structure)
Chemical structure of Deferasirox, showing the molecular framework with phenolic and triazole groups as part of its composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.